iKnowMed recognized as No. 1 oncology EHR by Black Book Research

For the sixth year in a row, iKnowMed electronic health record has been named the top-ranked EHR platform for oncologists and hematologists by Black Book Research, an industry-leading source for polling, surveys and market research.

iKnowMed was recognized for its superior focus on meeting the unique needs of community-based oncology practices. Implemented in nearly 650 sites of care nationwide and used by 1,700 providers, iKnowMed was the top-ranked oncology EHR across all practice sizes and delivery sites.

The EHR platform received number one rankings in nine key performance areas – the most in this year’s report – including support and customer care, client relationships and cultural fit, reliability, best of breed technology and process improvement, and strategic alignment with client goals.

iKnowMed Generation 2, developed in collaboration with oncologists in The US Oncology Network and supported by McKesson Specialty Health, was the first next generation EHR for oncology and hematology available. This innovative EHR platform seamlessly integrates with McKesson Specialty Health’s technology solutions.

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).

October 17, 2025

Vol.51 No.38

By Edison T. Liu

News Analysis Regulatory News

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Bowing to the growing animal rights movement, FDA and NIH have made policy changes to discourage animal testing, instead favoring alternative research models.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter and Jacquelyn Cobb

Guest Editorial

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context.

October 17, 2025

Vol.51 No.38

By Todd Burus, Caree McAfee and Pamela C. Hull

Why both somatic and germline genomic profiling are essential for precision oncology

Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations.

October 17, 2025

Vol.51 No.38

By Heather Hampel and David W. Craig

Cancer Policy

Dems push GOP to extend ACA credits as part of a deal to end the government shutdown

Millions of Americans with Affordable Care Act marketplace health insurance will face higher costs next year if Congress doesn’t extend enhanced premium tax credits that have made the plans more affordable for low- and middle-income enrollees.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter

Cancer Policy

Federal judge puts temporary block on new round of CDC and HHS layoffs

A federal judge issued a temporary restraining order on Oct. 15, ordering the Trump administration to reverse the wave of layoffs that the administration is using as a pressure tactic intended to force the Democrats to accept cuts to popular health programs and reopen the government.

October 17, 2025

Vol.51 No.38

By Sara Willa Ernst

iKnowMed recognized as No. 1 oncology EHR by Black Book Research

YOU MAY BE INTERESTED IN

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Why both somatic and germline genomic profiling are essential for precision oncology

Dems push GOP to extend ACA credits as part of a deal to end the government shutdown

Federal judge puts temporary block on new round of CDC and HHS layoffs

Renew today!

Subscriber content

Never miss an issue!

Login

iKnowMed recognized as No. 1 oncology EHR by Black Book Research

YOU MAY BE INTERESTED IN

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issueWhile cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Why both somatic and germline genomic profiling are essential for precision oncology

Dems push GOP to extend ACA credits as part of a deal to end the government shutdown

Federal judge puts temporary block on new round of CDC and HHS layoffs

Never miss an issue!

Login

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough